NCT04390477View on ClinicalTrials.gov

Study to Evaluate the Effect of a Probiotic in COVID-19

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

May 4, 2020

Primary Completion Date

March 21, 2021

Study Completion Date

April 30, 2021

Conditions
COVID-19Coronavirus Infection
Interventions
DIETARY_SUPPLEMENT

Probiotic

Oral daily capsule containing probiotic strains with maltodextrin as excipient, administrated for 30 days.

Trial Locations (2)

03293

Hospital Universitario del Vinalopó, Elche

03198

Hospital Universitario de Torrevieja, Torrevieja

Sponsors

Lead Sponsor

Bioithas SL
All Listed Sponsors
lead

Bioithas SL

INDUSTRY

NCT04390477 - Study to Evaluate the Effect of a Probiotic in COVID-19 | Biotech Hunter | Biotech Hunter